Construction of Gynecological Tumor Sample Library

Status

Not yet recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06204354

Enrollment

2500

Registered

2024-01-12

Start date

2024-01-31

Completion date

2027-01-31

Last updated

2024-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gynecologic Cancer

Brief summary

Constructing a gynecological tumor samples library, which is open and can be accessed.

Detailed description

This project is the construction and maintenance of a gynecological tumor sample library. It is supported by the National Key Laboratory of Difficult, Severe, and Rare Diseases at Peking Union Medical College Hospital of the Chinese Academy of Medical Sciences. This project will lay a clinical specimen foundation for exploring the molecular mechanisms of gynecological tumors in the future.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 80 Years

Inclusion criteria

1. An informed consent form was obtained. If the age is less than 18 years old, the consent form should be signed by the guardian. 2. Preoperative tumor burden assessment and intraoperative evaluation by the supervising physician (professor) suggest sampling is acceptable. 3. The research team believes that sampling is possible. 4. Having the relevant requirements for sample library storage. 5. Surgical treatment is performed at Peking Union Medical College Hospital.

Exclusion criteria

1. Not meeting all inclusion criteria. 2. The research team considers any circumstances or considerations that may hinder normal pathological evaluation.

Design outcomes

Primary

Measure	Time frame	Description
construction of Biobank	3 years	Biobank including gynecolgic cancer samples, including cervical cancer, endometrial cancer, ovarian cancer, vulva cancer, vaginal cancer, and others types

Secondary

Measure	Time frame	Description
Exploring the molecular mechanism based on biobank	3 year	Exploring the molecular mechanism of gynecological tumor pathogenesis based on biobank
Drug sensitivity detection based on biobank	3 year	Exploring drug sensitivity detection in gynecological tumors based on biobank

Outcome results